National Cancer Data Base, 2000 . CA Cancer J Clin 2000 ; 50 : 171 – 183 . 3 Dupont WD Page DL . Risk factors for breast cancer in women with proliferative breast disease . N Engl J Med 1985 ; 312 : 146 – 151 . 4 Slattery ML
Search Results
Sofia D. Merajver and Kara Milliron
Tobin Strom, Javier F. Torres-Roca, Akash Parekh, Arash O. Naghavi, Jimmy J. Caudell, Daniel E. Oliver, Jane L. Messina, Nikhil I. Khushalani, Jonathan S. Zager, Amod Sarnaik, James J. Mulé, Andy M. Trotti, Steven A. Eschrich, Vernon K. Sondak, and Louis B. Harrison
Background Node-positive cutaneous melanoma is heterogeneous, with 5-year survival rates ranging from 40% to 79%. 1 Many risk factors have been shown to be generally associated with regional recurrence following lymphadenectomy, including
Yi-Nong Chen, Ching-Wen Chiang, Yu-Hsiang Tsai, Wan-Ming Chen, Mingchih Chen, Ben-Chang Shia, Chun-Chi Huang, and Szu-Yuan Wu
of postoperative pneumonia (POP), which is high in patients with OCSCC who receive curative surgery, contributed to the high mortality and morbidity of these patients. 12 – 14 Consequently, identifying a modifiable risk factor for POP is crucial for
Krisda H. Chaiyachati, Diana Krause, Jessica Sugalski, Evan M. Graboyes, and Lawrence N. Shulman
infrastructure that is not suitable for patients with cancer; and inability to access ride services. 1 , 2 Transportation insecurity is a social risk factor 3 —adverse social conditions associated with poor health—that frequently co-occurs with other social risk
Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica N. Fornier, Robert F. Gagel, Rashmi Kumar, Georgia Litsas, Rana McKay, Donald A. Podoloff, Sandy Srinivas, and Catherine H. Van Poznak
effects on bone metabolism. The hormone deprivation state resulting from certain cancer therapies enhances osteoclastic bone resorption, promoting bone loss. Osteoporosis risk factors unique to patients with cancer include chemotherapy-induced menopause
Jeffrey Crawford, David C. Dale, Nicole M. Kuderer, Eva Culakova, Marek S. Poniewierski, Debra Wolff, and Gary H. Lyman
2005 ; 23 : 569 – 575 . 16. Lyman GH Lyman CH Agboola O . Risk models for predicting chemotherapy-induced neutropenia . Oncologist 2005 ; 10 : 427 – 437 . 17. Gomez H Hidalgo M Casanova L . Risk factors for treatment
John Charlson, Elizabeth C. Smith, Alicia J. Smallwood, Purushottam W. Laud, and Joan M. Neuner
along with other risk factors for fracture. 3 , 5 – 8 Although a few studies early in the use of AIs suggested that adherence to these guidelines was suboptimal, 9 – 13 there are few recent data. As consensus about the importance of AIs in HT regimens
Pilar de la Morena Barrio, María Ángeles Vicente Conesa, Enrique González-Billalabeitia, Edgar Urrego, Elisa García-Garre, Elena García-Martínez, Marta Zafra Poves, Vicente Vicente, and Francisco Ayala de la Peña
have DM. 14 , 15 Because DM is itself a cause of peripheral neuropathy, PIPN might be more prevalent and severe in patients with breast cancer and DM. However, the available evidence is limited for considering DM a risk factor for PIPN. Several case
Mathias Kvist Mejdahl, Birgitte Goldschmidt Mertz, Pernille Envold Bidstrup, and Kenneth Geving Andersen
Identify psychological risk factors for PPBCT that may be targeted in preventive interventions Background Persistent pain after breast cancer treatment (PPBCT) affects 25% to 60% of patients treated for breast cancer, 1 may persist for
Monira Alwhaibi, Usha Sambamoorthi, Suresh Madhavan, Thomas Bias, Kimberly Kelly, and James Walkup
). These dimensions are an individual's physical make-up, social support, access to care, health behaviors, psychological factors, biological risk factors, treatment factors, community resources, and geographic region. Methods Data Source SEER